2010
DOI: 10.1136/thx.2009.131391
|View full text |Cite
|
Sign up to set email alerts
|

Effects of steroid therapy on inflammatory cell subtypes in asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…Inhaled corticosteroids (ICS) are commonly prescribed for asthma and are considered to be more effective for Type 2-driven (eosinophilic) asthma. Inhaled corticosteroid use could also contribute to increased sputum neutrophils, another inflammatory phenotype [ 31 ]. Thus, ICS use may confound interpretation of VOCs in asthma.…”
Section: Discussionmentioning
confidence: 99%
“…Inhaled corticosteroids (ICS) are commonly prescribed for asthma and are considered to be more effective for Type 2-driven (eosinophilic) asthma. Inhaled corticosteroid use could also contribute to increased sputum neutrophils, another inflammatory phenotype [ 31 ]. Thus, ICS use may confound interpretation of VOCs in asthma.…”
Section: Discussionmentioning
confidence: 99%
“…Sputum is not routinely analyzed in children with acute respiratory symptoms, which could elucidate the finding and to avoid bias. Another hypothesis suggested would be that there would be an increase in neutrophils in the bronchial mucosa in response to treatment with corticosteroids inhaled by chemotaxis and inhibition of apoptosis of these cells in sputum 18,19 . In view of this, an initial eosinophilic pattern could hypothetically become mixed with treatment with inhaled corticosteroids.…”
Section: Discussionmentioning
confidence: 99%
“…The disease is characterized by intermittent airflow obstruction, which develops on a background of chronic inflammation of the airways, driven by CD4 + T-lymphocytes, and episodes of acute inflammation, typically dominated by eosinophils ( 2 ). Airway eosinophilia is well-described in asthma ( 3 , 4 ), and currently available anti-inflammatory treatments for asthma almost exclusively target eosinophilic airway inflammation and IgE secretion. However, increased attention is focusing on the clinical heterogeneity of asthma and the argument that failure to recognize and diagnose the underlying mechanisms of different asthma subtypes is a major limitation to progress in asthma control ( 5 ).…”
Section: Introductionmentioning
confidence: 99%